• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肝移植术后每周一次氟康唑预防真菌感染。

Once weekly fluconazole for antifungal prophylaxis post-liver transplantation.

机构信息

Department of Pharmacy Services, Barnes-Jewish Hospital, St. Louis, MO, USA.

出版信息

HPB (Oxford). 2013 Jul;15(7):541-7. doi: 10.1111/hpb.12006. Epub 2012 Nov 22.

DOI:10.1111/hpb.12006
PMID:23458063
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3692025/
Abstract

BACKGROUND

Invasive fungal infections (IFI) remain a significant cause of morbidity and mortality in orthotopic liver transplantation (OLT) recipients. In this retrospective study, the outcomes of a protocol using once weekly fluconazole for 3 months after OLT in low- and high-risk patients were reviewed.

METHODS

In total, 221 OLTs were evaluated in the 3-year period after institution of the new protocol to determine the incidence of IFI within 6 months post-OLT.

RESULTS

In this cohort, 11 IFIs developed during the 6-month post-transplant period, with the majority being non-albicans Candida. High-risk patients had a greater rate of IFI (16.7% versus 3.4%, P = 0.038) and a significantly longer intensive unit care (ICU) and hospital lengths of stay compared with low-risk patients. Patient and graft survival were similar between the groups. Our patient population appeared to be at low risk for IFI, with 92% of the entire cohort considered low risk.

DISCUSSION

Given the low incidence of IFI in the low-risk group and the possibility of such protocol selecting out for fluconazole-resistant fungi, the use of weekly fluconazole for 3 months may not be justifiable in low-risk OLT recipients. Given the increased resource utilization observed with IFI, further examination of a more intensive prophylactic strategy in high-risk patients may be warranted.

摘要

背景

侵袭性真菌感染(IFI)仍然是原位肝移植(OLT)受者发病率和死亡率的重要原因。在这项回顾性研究中,回顾了在 OLT 后使用每周一次氟康唑进行 3 个月的方案在低危和高危患者中的结果。

方法

在新方案实施后的 3 年内,共评估了 221 例 OLT,以确定 OLT 后 6 个月内 IFI 的发生率。

结果

在该队列中,有 11 例在移植后 6 个月内发生 IFI,其中大多数是非白色念珠菌属念珠菌。高危患者的 IFI 发生率更高(16.7%比 3.4%,P=0.038),与低危患者相比,重症监护病房(ICU)和住院时间明显延长。两组患者和移植物存活率相似。我们的患者人群似乎 IFI 风险较低,整个队列中有 92%的患者被认为是低危。

讨论

鉴于低危组 IFI 的发生率较低,并且该方案有可能选择出氟康唑耐药真菌,因此每周氟康唑使用 3 个月可能不适用于低危 OLT 受者。鉴于观察到IFI 导致资源利用增加,可能需要进一步检查高危患者更密集的预防策略。

相似文献

1
Once weekly fluconazole for antifungal prophylaxis post-liver transplantation.肝移植术后每周一次氟康唑预防真菌感染。
HPB (Oxford). 2013 Jul;15(7):541-7. doi: 10.1111/hpb.12006. Epub 2012 Nov 22.
2
Invasive fungal infections following liver transplantation: incidence, risk factors, survival, and impact of fluconazole-resistant Candida parapsilosis (2003-2007).肝移植术后侵袭性真菌感染:发生率、危险因素、生存率及氟康唑耐药近平滑假丝酵母菌(2003-2007 年)的影响。
Liver Transpl. 2012 Sep;18(9):1100-9. doi: 10.1002/lt.23467.
3
Antifungal prophylaxis in liver transplant recipients: one size does not fit all.肝移植受者的抗真菌预防:并非一概而论。
Transpl Infect Dis. 2016 Aug;18(4):538-44. doi: 10.1111/tid.12560. Epub 2016 Aug 2.
4
A targeted fungal prophylaxis protocol with static dosed fluconazole significantly reduces invasive fungal infection after liver transplantation.采用固定剂量氟康唑的靶向真菌预防方案可显著降低肝移植术后侵袭性真菌感染的发生率。
Transpl Infect Dis. 2019 Oct;21(5):e13156. doi: 10.1111/tid.13156. Epub 2019 Aug 23.
5
Randomized, double-blind trial of anidulafungin versus fluconazole for prophylaxis of invasive fungal infections in high-risk liver transplant recipients.随机、双盲临床试验:阿尼芬净对比氟康唑用于高危肝移植受者侵袭性真菌感染的预防。
Am J Transplant. 2014 Dec;14(12):2758-64. doi: 10.1111/ajt.12963. Epub 2014 Nov 6.
6
[The impact of itraconazole versus fluconazole on the prevention of postoperative invasive fungal infections after orthotopic liver transplantation].伊曲康唑与氟康唑对原位肝移植术后侵袭性真菌感染预防的影响
Zhonghua Nei Ke Za Zhi. 2007 Nov;46(11):911-3.
7
Association of fungal infection and increased mortality in liver transplant recipients.肝移植受者真菌感染与死亡率增加的关联。
Am J Surg. 2000 May;179(5):426-30. doi: 10.1016/s0002-9610(00)00366-4.
8
Antifungal agents for preventing fungal infections in solid organ transplant recipients.用于预防实体器官移植受者真菌感染的抗真菌药物。
Cochrane Database Syst Rev. 2004(3):CD004291. doi: 10.1002/14651858.CD004291.pub2.
9
A reduced dose of fluconazole as primary antifungal prophylaxis is not associated with increased risk of invasive fungal infections after allogeneic stem cell transplantation from a HLA identical sibling.对于接受来自 HLA 同型同胞的异基因干细胞移植的患者,降低氟康唑剂量作为主要抗真菌预防措施与侵袭性真菌感染风险增加无关。
Transpl Infect Dis. 2018 Aug;20(4):e12906. doi: 10.1111/tid.12906. Epub 2018 May 16.
10
Invasive fungal infections in low-risk liver transplant recipients: a multi-center prospective observational study.低风险肝移植受者的侵袭性真菌感染:一项多中心前瞻性观察研究。
Am J Transplant. 2006 Feb;6(2):386-91. doi: 10.1111/j.1600-6143.2005.01176.x.

引用本文的文献

1
Asian Pacific Association for the Study of the Liver clinical practice guidelines on liver transplantation.亚太肝病学会肝脏移植临床实践指南。
Hepatol Int. 2024 Apr;18(2):299-383. doi: 10.1007/s12072-023-10629-3. Epub 2024 Feb 28.
2
Invasive fungal infection before and after liver transplantation.肝移植前后的侵袭性真菌感染
World J Gastroenterol. 2020 Dec 21;26(47):7485-7496. doi: 10.3748/wjg.v26.i47.7485.
3
Infections after orthotopic liver transplantation.原位肝移植后的感染
J Clin Exp Hepatol. 2014 Dec;4(4):347-60. doi: 10.1016/j.jceh.2014.07.004. Epub 2014 Jul 24.

本文引用的文献

1
The economic costs to United States hospitals of invasive fungal infections in transplant patients.美国移植患者侵袭性真菌感染给医院带来的经济成本。
Am J Infect Control. 2011 May;39(4):e15-20. doi: 10.1016/j.ajic.2010.06.009. Epub 2010 Oct 20.
2
Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America.念珠菌病管理临床实践指南:美国传染病学会2009年更新版
Clin Infect Dis. 2009 Mar 1;48(5):503-35. doi: 10.1086/596757.
3
Outcomes of antifungal prophylaxis in high-risk liver transplant recipients.高危肝移植受者抗真菌预防治疗的结果
Transpl Infect Dis. 2009 Feb;11(1):40-8. doi: 10.1111/j.1399-3062.2008.00361.x. Epub 2008 Dec 19.
4
Antifungal management practices in liver transplant recipients.肝移植受者的抗真菌治疗实践
Am J Transplant. 2008 Feb;8(2):426-31. doi: 10.1111/j.1600-6143.2007.02089.x. Epub 2008 Jan 7.
5
Effect of prophylaxis on fungal infection and costs for high-risk liver transplant recipients.预防性治疗对高危肝移植受者真菌感染及费用的影响。
Liver Transpl. 2007 Dec;13(12):1743-50. doi: 10.1002/lt.21331.
6
Systematic review and meta-analysis of antifungal agents for preventing fungal infections in liver transplant recipients.肝移植受者预防真菌感染的抗真菌药物系统评价与荟萃分析。
Eur J Clin Microbiol Infect Dis. 2006 Sep;25(9):549-61. doi: 10.1007/s10096-006-0182-3.
7
Antifungal prophylaxis in liver transplant patients: a systematic review and meta-analysis.肝移植患者的抗真菌预防:一项系统评价与荟萃分析。
Liver Transpl. 2006 May;12(5):850-8. doi: 10.1002/lt.20690.
8
Invasive fungal infections in low-risk liver transplant recipients: a multi-center prospective observational study.低风险肝移植受者的侵袭性真菌感染:一项多中心前瞻性观察研究。
Am J Transplant. 2006 Feb;6(2):386-91. doi: 10.1111/j.1600-6143.2005.01176.x.
9
Association of fungal infection and increased mortality in liver transplant recipients.肝移植受者真菌感染与死亡率增加的关联。
Am J Surg. 2000 May;179(5):426-30. doi: 10.1016/s0002-9610(00)00366-4.
10
The independent role of cytomegalovirus as a risk factor for invasive fungal disease in orthotopic liver transplant recipients. Boston Center for Liver Transplantation CMVIG-Study Group. Cytogam, MedImmune, Inc. Gaithersburg, Maryland.巨细胞病毒作为原位肝移植受者侵袭性真菌病危险因素的独立作用。波士顿肝移植中心CMVIG研究组。赛美维,MedImmune公司,马里兰州盖瑟斯堡。
Am J Med. 1997 Aug;103(2):106-13. doi: 10.1016/s0002-9343(97)80021-6.